Cambrian Biopharma

Developer of medicines and therapies

placeBrooklyn, New York, United States calendar_todayFounded 2019 groups48 employees language cambrianbio.com

Registered entities

Social engagement

Social engagement: 14.6K social following, 7 posts in the last 12 months — around the industry typical range.

Investor mix

22 investors on record; lead investors include Apeiron Investment Group, Future Ventures, Catalio Capital Management, Galaxy.

Investor typeCountShare
Venture capital1777%
Private equity15%
Other / undisclosed418%

Recent activity

18 Jun 2026
Product launch
ATX-304
17 Jun 2026
Leadership hire
Director, R&D Project Management
9 Jun 2026
Leadership hire
Clinical Trial Associate
Coming soon